...
首页> 外文期刊>Human Molecular Genetics >Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels
【24h】

Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels

机译:鉴定涉及血清铁水平生理调节的TFR2基因常见变异

获取原文

摘要

The genetic determinants of variation in iron status are actively sought, but remain incompletely understood. Meta-analysis of two genome-wide association (GWA) studies and replication in three independent cohorts was performed to identify genetic loci associated in the general population with serum levels of iron and markers of iron status, including transferrin, ferritin, soluble transferrin receptor (sTfR) and sTfR–ferritin index. We identified and replicated a novel association of a common variant in the type-2 transferrin receptor (TFR2) gene with iron levels, with effect sizes highly consistent across samples. In addition, we identified and replicated an association between the HFE locus and ferritin and confirmed previously reported associations with the TF, TMPRSS6 and HFE genes. The five replicated variants were tested for association with expression levels of the corresponding genes in a publicly available data set of human liver samples, and nominally statistically significant expression differences by genotype were observed for all genes, although only rs3811647 in the TF gene survived the Bonferroni correction for multiple testing. In addition, we measured for the first time the effects of the common variant in TMPRSS6, rs4820268, on hepcidin mRNA in peripheral blood (n = 83 individuals) and on hepcidin levels in urine (n = 529) and observed an association in the same direction, though only borderline significant. These functional findings require confirmation in further studies with larger sample sizes, but they suggest that common variants in TMPRSS6 could modify the hepcidin-iron feedback loop in clinically unaffected individuals, thus making them more susceptible to imbalances of iron homeostasis.
机译:积极寻找铁状态变化的遗传决定因素,但仍未完全了解。进行了两项全基因组关联研究(GWA)研究并在三个独立的队列中进行复制的荟萃分析,以鉴定一般人群中与血清铁水平和铁状态标记(包括转铁蛋白,铁蛋白,可溶性转铁蛋白受体)相关的遗传基因座( sTfR)和sTfR-铁蛋白指数。我们鉴定并复制了2型转铁蛋白受体(TFR2)基因中常见变异与铁水平的新型关联,且效应大小在样品中高度一致。此外,我们鉴定并复制了HFE基因座和铁蛋白之间的关联,并确认了先前报道的与TF,TMPRSS6和HFE基因的关联。测试了这五个复制的变体是否与人类肝脏样品的公开数据集中的相应基因的表达水平相关联,并且在所有基因上均观察到了基因型的名义上统计学上显着的差异,尽管在TF基因中只有rs3811647幸免于Bonferroni更正多次测试。此外,我们首次测量了TMPRSS6中的常见变体rs4820268对外周血中hepcidin mRNA(n = 83个人)和尿液中hepcidin水平(n = 529)的影响,并观察到两者之间存在关联方向,尽管只有临界线有效。这些功能性发现需要在更大样本量的进一步研究中得到证实,但它们表明TMPRSS6中的常见变异体可能会改变临床上未受影响的个体中的铁调素-铁反馈回路,从而使他们更容易受到铁稳态失衡的影响。

著录项

  • 来源
    《Human Molecular Genetics 》 |2011年第6期| p.1232-1240| 共9页
  • 作者单位

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Clinical Research Branch, National Institute on Aging, 21225 Baltimore, MD, USA,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,|Department of Experimental and Diagnostic Medicine, University of Ferrara, 44121 Ferrara, Italy,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,|Genetics Program, School of Medicine, Boston University, 02118 Boston, MA, USA,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

    Clinical Research Branch, National Institute on Aging, 21225 Baltimore, MD, USA,;

    Laboratory of Epidemiology, Demography and Biometry and;

    Laboratory of Neurogenetics, National Institute on Aging, 20892 Bethesda, MD, USA,;

    Geriatric Rehabilitation Unit, Azienda Sanitaria Firenze (ASF), 50100 Florence, Italy,;

    Zentrallabor, Molekularbiologie, Salzburger Landeskliniken, 5020 Salzburg, Austria,;

    Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, 46201 Indianapolis, IN, USA,;

    Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, 46201 Indianapolis, IN, USA,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,|Institute of Applied Genomics, IGA, 33100 Udine, Italy,;

    Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, 6020 Innsbruck, Austria,;

    Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, 93047 Regensburg, Germany,;

    Pacific Biosciences, 94025 Menlo Park, CA, USA,;

    Department of Transfusion Medicine, Franz Tappeiner Hospital, 39012 Merano, Italy,;

    Laboratory of Genetics, National Institute on Aging, 21224 Baltimore, MD, USA,;

    Clinical Research Branch, National Institute on Aging, 21225 Baltimore, MD, USA,;

    Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, 46201 Indianapolis, IN, USA,;

    Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy;

    Affiliated Institute of the University of Lübeck, 23538 Lübeck, Germany,;

    Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, 6020 Innsbruck, Austria,;

    Istituto di Neurogenetica e Neurofarmacologia del CNR, 09042 Monserrato, Cagliari, Italy,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号